DE60115433D1 - Verfahren zur behandlung von chronischen geschwüren - Google Patents
Verfahren zur behandlung von chronischen geschwürenInfo
- Publication number
- DE60115433D1 DE60115433D1 DE60115433T DE60115433T DE60115433D1 DE 60115433 D1 DE60115433 D1 DE 60115433D1 DE 60115433 T DE60115433 T DE 60115433T DE 60115433 T DE60115433 T DE 60115433T DE 60115433 D1 DE60115433 D1 DE 60115433D1
- Authority
- DE
- Germany
- Prior art keywords
- ulcer
- matrix
- treatment
- chronic diseases
- oxide inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/18—Materials or treatment for tissue regeneration for hair reconstruction
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20811600P | 2000-05-31 | 2000-05-31 | |
US208116P | 2000-05-31 | ||
PCT/US2001/017387 WO2001091774A2 (en) | 2000-05-31 | 2001-05-30 | Method of treating chronic ulcers |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60115433D1 true DE60115433D1 (de) | 2006-01-05 |
DE60115433T2 DE60115433T2 (de) | 2006-08-03 |
Family
ID=22773242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60115433T Expired - Lifetime DE60115433T2 (de) | 2000-05-31 | 2001-05-30 | Verfahren zur behandlung von chronischen geschwüren |
Country Status (8)
Country | Link |
---|---|
US (2) | US6992062B2 (de) |
EP (1) | EP1289537B1 (de) |
AT (1) | ATE311192T1 (de) |
AU (3) | AU2001265151A1 (de) |
CA (2) | CA2410965C (de) |
DE (1) | DE60115433T2 (de) |
NZ (1) | NZ523461A (de) |
WO (2) | WO2001091774A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7828749B2 (en) * | 1996-05-17 | 2010-11-09 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
MXPA05009803A (es) * | 2003-03-13 | 2006-04-18 | Cheryl M Burgess | Metodos para administrar un material en un paciente para realce dermico. |
JP2005269232A (ja) * | 2004-03-18 | 2005-09-29 | Renesas Technology Corp | 周波数混合器 |
JP2008500347A (ja) * | 2004-05-24 | 2008-01-10 | ニュー・ヨーク・ユニヴァーシティー | 高血糖症による血糖の急激な増加及び/又は急激な遊離脂肪酸流動の増加の病理学的影響の治療方法又は予防方法 |
WO2009137074A1 (en) * | 2008-05-06 | 2009-11-12 | Indigene Pharmaceuticals, Inc. | Compositions and methods for treating diabetic ulcers |
US10098857B2 (en) | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
EP2236617A1 (de) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Verfahren zur Endsterilisierung von biofunktionalen Zusammensetzungen |
CN102695500A (zh) | 2009-11-09 | 2012-09-26 | 聚光灯技术合伙有限责任公司 | 多糖基水凝胶 |
AU2010314994B2 (en) | 2009-11-09 | 2016-10-06 | Spotlight Technology Partners Llc | Fragmented hydrogels |
CA2854160A1 (en) | 2011-11-02 | 2013-05-10 | Halscion, Inc. | Methods and compositions for wound treatment |
MX352601B (es) | 2011-12-23 | 2017-11-30 | Pioneer Surgical Tech | Matriz continua con particulas osteoconductoras dispersadas en ella, método para formarla y método para regenerar hueso con ella. |
WO2017069113A1 (ja) * | 2015-10-20 | 2017-04-27 | 国立大学法人 東京医科歯科大学 | 発毛促進組成物およびその使用 |
KR102085404B1 (ko) * | 2016-08-31 | 2020-03-05 | 주식회사 에스엔비아 | 부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들 |
WO2018113634A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
CN110121331B (zh) | 2016-12-21 | 2022-09-16 | 联合利华知识产权控股有限公司 | 含有难溶性化合物的个人护理组合物 |
CN110325168B (zh) | 2016-12-21 | 2022-10-21 | 联合利华知识产权控股有限公司 | 含有胱氨酸的个人护理组合物 |
WO2018113635A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Topical skin lightening additive and composition with amino acids and nicotinamide compounds |
WO2019055490A1 (en) | 2017-09-14 | 2019-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | PACKAGING OF IRRADIED FABRIC FOR FAT GREETING RETENTION |
CN112165927B (zh) | 2018-05-23 | 2024-01-30 | 联合利华知识产权控股有限公司 | 纳米乳液及其制备方法 |
CN113679846B (zh) * | 2021-08-31 | 2023-05-09 | 佛山市第一人民医院(中山大学附属佛山医院) | 一种毛发再生剂及其制备方法和应用 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198479A (en) | 1979-03-30 | 1980-04-15 | Merck & Co., Inc. | Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells |
US4520821A (en) | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US5852009A (en) | 1984-03-19 | 1998-12-22 | The Rockefeller University | Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon |
US4665192A (en) * | 1984-03-19 | 1987-05-12 | The Rockefeller University | 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole |
US4868121A (en) | 1985-02-07 | 1989-09-19 | Mcdonnell Douglas Corporation | Islet isolation process |
NO166836C (no) | 1985-03-14 | 1991-09-11 | Univ California | Fremgangsmaate for behandling av et organtransplantat. |
EP0213908A3 (de) | 1985-08-26 | 1989-03-22 | Hana Biologics, Inc. | Transplantierbares Kunstgewebe und Verfahren |
US4902295A (en) * | 1985-08-26 | 1990-02-20 | Hana Biologics, Inc. | Transplantable artificial tissue |
GB8604497D0 (en) | 1986-02-24 | 1986-04-03 | Connaught Lab | Separation of islets of langerhans |
FR2600076A1 (fr) | 1986-06-12 | 1987-12-18 | Fond Ctre Nal Transfusion | Milieu de culture comportant de l'albumine humaine, procede de preparation d'un produit injectable a partir de ce milieu, produit obtenu et son utilisation, composition obtenue |
US5079160A (en) | 1987-06-08 | 1992-01-07 | Lacy Paul E | Method to isolate clusters of cell subtypes from organs |
US5457093A (en) * | 1987-09-18 | 1995-10-10 | Ethicon, Inc. | Gel formulations containing growth factors |
EP0403650B1 (de) | 1988-03-09 | 1994-05-25 | Terumo Kabushiki Kaisha | Für zellen eindringbares medizinisches material und kunsthaut |
US4950483A (en) * | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
EP0363125A3 (de) | 1988-10-03 | 1990-08-16 | Hana Biologics Inc. | Produkt, enthaltend vermehrungsfähige Bauchspeicheldrüsen-Endokrinezellen, und Verfahren |
US4957902A (en) | 1988-12-20 | 1990-09-18 | Board Of Regents, The University Of Texas System | Peptide inhibitors of wound contraction |
US5059588A (en) * | 1989-10-13 | 1991-10-22 | Procyte Corporation, Incorporated | Methods and compositions for healing bone using gly his lys: copper |
WO1991009119A1 (en) | 1989-12-13 | 1991-06-27 | Trancel Corporation | Improved alginate microcapsules, methods of making and using same |
US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
ES2107537T3 (es) | 1991-04-25 | 1997-12-01 | Univ Brown Res Found | Vehiculo inmunoaislante biocompatible implantable para suministrar productos terapeuticos seleccionados. |
US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
CA2071137A1 (en) | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
US5591709A (en) * | 1991-08-30 | 1997-01-07 | Life Medical Sciences, Inc. | Compositions and methods for treating wounds |
WO1994015589A1 (en) | 1992-12-30 | 1994-07-21 | Clover Consolidated, Limited | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
US5358969A (en) | 1991-12-16 | 1994-10-25 | Washington University | Method of inhibiting nitric oxide formation |
US5246971A (en) * | 1991-12-16 | 1993-09-21 | Washington University | Method of inhibiting nitric oxide formation |
WO1993016685A1 (en) | 1992-02-24 | 1993-09-02 | Encelle, Inc. | Bioartificial endocrine device |
US5824331A (en) * | 1992-02-24 | 1998-10-20 | Encelle, Inc. | Bioartificial devices and cellular matrices therefor |
US5830492A (en) | 1992-02-24 | 1998-11-03 | Encelle, Inc. | Bioartificial devices and cellular matrices therefor |
US5834005A (en) | 1992-02-24 | 1998-11-10 | Encelle, Inc. | Bioartificial devices and cellular matrices therefor |
US6231881B1 (en) * | 1992-02-24 | 2001-05-15 | Anton-Lewis Usala | Medium and matrix for long-term proliferation of cells |
AU3733293A (en) | 1992-02-25 | 1993-09-13 | Alteon Inc. | Method and agents for promoting wound healing |
EP0641196B1 (de) | 1992-05-29 | 2001-08-22 | Vivorx, Incorporated | Mikroverkapselung von zellen |
EP0655910A4 (de) | 1992-07-29 | 1996-02-28 | Univ Washington | Verwendung eines beutels zur implantation von lebenden zellen. |
US5262055A (en) | 1992-10-19 | 1993-11-16 | The University Of Utah | Implantable and refillable biohybrid artificial pancreas |
DE4431598C2 (de) | 1993-03-03 | 1997-03-20 | Michael Sittinger | Verfahren zum Herstellen eines Implantates aus Zellkulturen |
ATE317397T1 (de) | 1993-11-17 | 2006-02-15 | Athena Neurosciences Inc | Transparente flüssigkeit zur verabreichung von verkapselten medikamenten |
EP1418228B1 (de) | 1994-01-13 | 2006-03-15 | The Rogosin Institute | Makroeingekapselte sekretorische Zellen |
US5487899A (en) * | 1994-01-31 | 1996-01-30 | Jess Clarke & Sons, Inc. | Wound healing |
US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
US5840059A (en) * | 1995-06-07 | 1998-11-24 | Cardiogenesis Corporation | Therapeutic and diagnostic agent delivery |
CA2179341A1 (en) | 1996-04-12 | 1997-10-13 | Gregory S. Korbutt | Methods for isolating, enriching and increasing the maturation of cells |
JP2000511512A (ja) | 1996-05-03 | 2000-09-05 | イノジェネティックス・ナムローゼ・フェンノートシャップ | 酸化ポリサッカライドで架橋したゼラチンを含有する新規医薬 |
US5972332A (en) | 1997-04-16 | 1999-10-26 | The Regents Of The University Of Michigan | Wound treatment with keratinocytes on a solid support enclosed in a porous material |
EP0986408B1 (de) | 1997-06-03 | 2005-05-11 | Innogenetics N.V. | Neue arzneimittel auf der basis von polymeren aus mit methacrylamid modifizierter gelatine |
EP1041996A4 (de) | 1997-12-22 | 2003-05-14 | Human Genome Sciences Inc | Keratinozyten wachstumsfaktor-2 formulierungen |
EP1094849B1 (de) | 1998-07-10 | 2006-05-17 | Encelle, Inc. | Methoden zur verbesserung der vaskularisierung und förderung der wundheilung |
US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
US6046160A (en) * | 1999-07-22 | 2000-04-04 | Deroyal Industries, Inc. | Composition and method for enhancing wound healing |
US6491953B1 (en) * | 2000-01-07 | 2002-12-10 | Amcol International Corporation | Controlled release compositions and method |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
-
2001
- 2001-05-30 AU AU2001265151A patent/AU2001265151A1/en not_active Abandoned
- 2001-05-30 US US09/870,424 patent/US6992062B2/en not_active Expired - Fee Related
- 2001-05-30 EP EP01937796A patent/EP1289537B1/de not_active Expired - Lifetime
- 2001-05-30 US US09/870,414 patent/US7700660B2/en not_active Expired - Fee Related
- 2001-05-30 CA CA2410965A patent/CA2410965C/en not_active Expired - Fee Related
- 2001-05-30 NZ NZ523461A patent/NZ523461A/en not_active IP Right Cessation
- 2001-05-30 AU AU6349501A patent/AU6349501A/xx active Pending
- 2001-05-30 DE DE60115433T patent/DE60115433T2/de not_active Expired - Lifetime
- 2001-05-30 CA CA2410968A patent/CA2410968C/en not_active Expired - Fee Related
- 2001-05-30 WO PCT/US2001/017387 patent/WO2001091774A2/en active IP Right Grant
- 2001-05-30 WO PCT/US2001/017386 patent/WO2001091773A2/en active Application Filing
- 2001-05-30 AU AU2001263495A patent/AU2001263495B2/en not_active Ceased
- 2001-05-30 AT AT01937796T patent/ATE311192T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE311192T1 (de) | 2005-12-15 |
US20020065222A1 (en) | 2002-05-30 |
CA2410965A1 (en) | 2001-12-06 |
WO2001091774A2 (en) | 2001-12-06 |
EP1289537B1 (de) | 2005-11-30 |
AU2001265151A1 (en) | 2001-12-11 |
US6992062B2 (en) | 2006-01-31 |
WO2001091773A2 (en) | 2001-12-06 |
US7700660B2 (en) | 2010-04-20 |
AU2001263495B2 (en) | 2005-06-02 |
AU6349501A (en) | 2001-12-11 |
CA2410965C (en) | 2010-09-14 |
NZ523461A (en) | 2004-11-26 |
WO2001091773A3 (en) | 2002-05-02 |
US20020077277A1 (en) | 2002-06-20 |
CA2410968A1 (en) | 2001-12-06 |
DE60115433T2 (de) | 2006-08-03 |
WO2001091774A3 (en) | 2002-05-02 |
EP1289537A2 (de) | 2003-03-12 |
CA2410968C (en) | 2011-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60115433D1 (de) | Verfahren zur behandlung von chronischen geschwüren | |
MXPA04004170A (es) | Tratamiento del sindrome de resitencia a la insulina y diabetes de tipo 2 con inhibidores de pde9. | |
ATE390142T1 (de) | Synergistische zusammensetzung zur behandlung von diabetes mellitus | |
DE60227658D1 (de) | Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren | |
ES2166783T3 (es) | Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii. | |
DE60312309D1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
TW200509956A (en) | Compositions and methods for treatment of rosacea | |
ATE287271T1 (de) | Verwendung von vegf zur herstellung eines medikaments zur behandlung oder verhinderung der intimalen hyperplasie und verabreichungsgerät | |
ATE447948T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
AU2001263495A1 (en) | Method of treating chronic ulcers | |
NO994640D0 (no) | Hostestillende midler | |
DE69902520D1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
EA200501549A1 (ru) | Применение экспрессирующего вектора, кодирующего ингибитор il-18, для лечения и/или профилактики заболевания сердца и способ лечения заболевания сердца | |
DE69822810D1 (de) | Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x | |
EA200600284A1 (ru) | Дооперационное лечение послеоперационной боли | |
DE69911212D1 (de) | Anwendung der hemoproteine in der therapie | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
DE69733321D1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine | |
ATE484293T1 (de) | Verfahren zur vorbeugung oder behandlung von diabetes | |
RU94003799A (ru) | Способ лечения псороптозов животных | |
EP1011672A4 (de) | Verbindungen mit analgetischem effekt und zusammenstellungen die diese enthalten | |
RU93048242A (ru) | Способ гляциопунктуры и игла для его осуществления | |
DE69430807D1 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen | |
DE60134656D1 (de) | Hilfsmittel und methoden zur transdermalen applikation von felodipin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |